Parse Biosciences is a Seattle-based startup providing researchers access to the most scalable single cell sequencing platform available. With technology founded on the principles of SPLiT-seq, published in Science in 2018, Parse Biosciences' mission is to accelerate progress in scientific research as well as human health. Single-cell sequencing has already enabled groundbreaking discoveries that have led to new understandings in cancer treatment, tissue repair, stem cell therapy, the immune system and much more. At Parse Biosciences we provide researchers with the ability to perform single cell sequencing with unprecedented scale and ease.

We're a real estate startup using financial innovation to back home buyers. In 2015, we set out to reimagine a generally broken experience - one buyer at a time. We believed that speed, transparency, and end-to-end service were necessities to improve an industry that hadn't evolved in decades. Since then, we've helped hundreds of people buy homes with a truly seamless process. We've broken down each step of the journey and systematically reshaped it with comprehensive consumer education, segmented expertise, financial innovation, and on-demand technology. And we're just getting started.